Novozymes A/S B buy RudolfL
Start price
11.09.20
/
50%
€55.52
Target price
04.11.21
€63.00
Performance (%)
18.70%
End price
05.11.21
€65.90
Summary
This prediction ended on 05.11.21 with a price of €65.90. The prediction had a final performance of 18.70%. A total of €0.71 was paid as dividends for this prediction. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novozymes A/S B | 1.845% | 1.845% | -0.213% | 25.111% |
| iShares Core DAX® | 1,00 % | 4,83 % | 8,15 % | 62,60 % |
| iShares Nasdaq 100 | 2,70 % | -1,72 % | 26,92 % | 88,13 % |
| iShares Nikkei 225® | 3,52 % | -3,51 % | 48,06 % | 78,11 % |
| iShares S&P 500 | 1,77 % | 1,27 % | 23,58 % | 70,47 % |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
In the thread Trading Novozymes A/s Nam. B
Die von RudolfL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€46.87
26.01.20
26.01.20
€53.00
13.08.20
13.08.20
5.33%
13.08.20
13.08.20
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected
